Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2005-09-13
2005-09-13
Henley, III, Raymond J. (Department: 1614)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
active
06943164
ABSTRACT:
Levosimendan solutions for pharmaceutical use, and particularly for intravenous administration. The solutions of the invention have enhanced stability and they are particularly useful as infusion or injection solutions or infusion concentrates. Levosimendan is useful in the treatment of congestive heart failure.
REFERENCES:
patent: 5424428 (1995-06-01), Nore et al.
patent: 5512571 (1996-04-01), Nore et al.
patent: 5512572 (1996-04-01), Haikala et al.
patent: 5569657 (1996-10-01), Nore et al.
patent: 6180789 (2001-01-01), Timmerbacka et al.
patent: 6730673 (2004-05-01), Backstrom et al.
patent: 0 565 546 (1993-10-01), None
patent: WO 93/21921 (1993-11-01), None
patent: WO 97/35841 (1997-10-01), None
patent: WO 98/01111 (1998-01-01), None
Physical Pharmacy, Martin et al. (eds.), Second Edition, published 1969 by Lea & Febiger (Philadelphia), pp 199-201.
Sandell et al., “Pharmacokinetics of Levosimendan in Healthy Volunteers and Patients with Congestive Heart Failure,” Journal of Cardiovascular Pharmacology, 26(Suppl. 1):S57-S62 (1995).
Sundberg et al., “Hemodynamic and Neurohumoral Effects of Levosimendan, a New Calcium Sensitizer, at Rest and During Exercise in Healthy Men,” The American Journal of Cardiology, vol. 75, pp. 1061-1066 (1995).
Antilla et al., “Studies on Psychomotoric Effects and Pharmacokinetic Interactions of the New Calcium Sensitizing Drug Levosimendan and Ethanol,” Arzneim-Forsch./Drug Res. 47 (II), Nr, 7 , pp. 816-820 (1997).
Co-pending U.S. Appl. No. 10/070,689, filed, Jul. 26, 2002.
Bäckström Reijo
Granvik Päivi
Haikala Ritva
Pelttari Sirpa
Saukko Eva
Finnegan Henderson Farabow Garrett & Dunner LLP
Henley III Raymond J.
Orion Corporation
LandOfFree
Pharmaceutical solutions of levosimendan does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Pharmaceutical solutions of levosimendan, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pharmaceutical solutions of levosimendan will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3374681